Healthlead PCL (BKK:HL) Beginning Cash Position: ฿40 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:HL Healthlead PCL BKK:HL
74 GF Score
Price ฿4.84
GF Value ฿9.97
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Healthlead PCL Beginning Cash Position?

Healthlead PCL BKK:HL -1.63% 74 Beginning Cash Position is ฿40 Mil as of Jun. 2026. GuruFocus rates BKK:HL with a GF Score™ of 74/100 and a GF Value™ of ฿9.97 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Healthlead PCL's Beginning Cash Position for the quarter that ended in Jun. 2026 was ฿40 Mil.

Healthlead PCL's quarterly Beginning Cash Position declined from Dec. 2025 (฿59 Mil) to Mar. 2026 (฿37 Mil) but then increased from Mar. 2026 (฿37 Mil) to Jun. 2026 (฿40 Mil).

Healthlead PCL's annual Beginning Cash Position increased from Dec. 2023 (฿146 Mil) to Dec. 2024 (฿335 Mil) but then declined from Dec. 2024 (฿335 Mil) to Dec. 2025 (฿169 Mil).

Healthlead PCL Beginning Cash Position Related Terms

Healthlead PCL Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Healthlead PCL's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthlead PCL Beginning Cash Position Chart

Healthlead PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 34.85 705.01 146.35 334.81 168.67

Healthlead PCL Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 156.48 33.54 58.93 37.43 39.65
BKK:HL
74GF Score
Healthlead PCL BKK:HL
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healthlead PCL Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of ฿40 Mil mean?
Healthlead PCL (BKK:HL) has a Beginning Cash Position of ฿40 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Healthlead PCL and its competitors.
Is Healthlead PCL's Beginning Cash Position too high?
Healthlead PCL's current Beginning Cash Position is ฿40 Mil. Overall, Healthlead PCL has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthlead PCL's Beginning Cash Position compare to competitors?
Healthlead PCL's Beginning Cash Position of ฿40 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Healthcare Providers & Services company?
A good Beginning Cash Position depends on the Healthcare Providers & Services industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Healthlead PCL and its competitors. Healthlead PCL's current Beginning Cash Position is ฿40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthlead PCL stock overvalued right now?
Based on GuruFocus' analysis, Healthlead PCL (BKK:HL) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿9.97, compared to a current price of ฿4.84 — trading 51.5% below its estimated fair value. The current Beginning Cash Position is ฿40 Mil. Healthlead PCL's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Healthlead PCL (BKK:HL), the current Beginning Cash Position is ฿40 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healthlead PCL (BKK:HL) Overvalued in 2026?

Based on GuruFocus' analysis, Healthlead PCL stock appears to be undervalued. The current stock price of ฿4.84 is trading 51.5% below its estimated GF Value™ of ฿9.97. GuruFocus considers Healthlead PCL to be Significantly Undervalued.

Key valuation signals for BKK:HL:

  • Beginning Cash Position: ฿40 Mil
  • GF Value™: ฿9.97 vs. price of ฿4.84 (51.5% below fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the BKK:HL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healthlead PCL Business Description

Address 99/4 Moo 10, Bang Muang Sub-District, Bang-Yai District, Nonthaburi, THA, 11140
Healthlead PCL is a holding company. Along with its subsidiaries, it operates a pharmacy business under iCare, Pharmax, vitaminclub, and Super Drug brands, distributing medicines, medical supplies, cosmeceuticals, dietary supplements, medical devices, and other healthcare products. Additionally, it is involved in co-inventing and co-developing healthcare products in collaboration with external research teams and contract manufacturers, producing and distributing its own branded products. Geographically, the group operates only in Thailand.
74GF Score

Get the complete analysis for BKK:HL

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿4.84
Price
฿9.97
GF Value